CIK 0001140859 · Large accelerated filer
Cencora, Inc.
Sign in to watch- Ticker
- COR
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233079390
- Phone
- 610-727-7000
- Business address
- 1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
- Former names
- AMERISOURCEBERGEN CORP, AMERISOURCE BERGEN CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,020,270
- in 5 filings, $946K under 10b5-1 plans
Net −$5,020,270. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-19 | Mauch Robert P. President & CEO | Sale 10b5-1 | −4,969 | $291.43 | $1.4M | 45,838 |
| 2025-05-19 | Mauch Robert P. President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −3,225 | 32,252 | ||
| 2025-05-14 | GREENBERG LON R Director | Sale | −3,000 | $279.05 | $837K | 17,851 |
| 2025-05-01 | NALLY DENNIS M Director | Grant or award | +121 | $290.43 | $35K | 13,251 |
| 2025-05-01 | Baumann Werner Director | Grant or award | +125 | $290.43 | $36K | 2,896 |
| 2025-05-01 | Tyler Lauren M Director | Grant or award | +104 | $290.43 | $30K | 2,875 |
| 2025-04-23 | Cleary James F Chief Financial Officer | Other disposition | −35,000 | 114,293.35 | ||
| 2025-04-22 | COLLIS STEVEN H Executive Chairman | Option exercise 10b5-1 | +12,579 | $86.09 | $1.1M | 330,491.67 |
| 2025-04-22 | COLLIS STEVEN H Executive Chairman | Sale 10b5-1 | −14,579 | $281.81 | $4.1M | 315,912.67 |
| 2025-04-22 | COLLIS STEVEN H Executive Chairman | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −12,579 | 138,363 | ||
| 2025-04-21 | Mauch Robert P. President & CEO | Option exercise 10b5-1 | +3,225 | $86.09 | $278K | 52,551 |
| 2025-04-21 | Mauch Robert P. President & CEO | Sale 10b5-1 | −4,969 | $289.33 | $1.4M | 47,582 |
| 2025-04-21 | Mauch Robert P. President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −3,225 | 35,477 | ||
| 2025-03-25 | COLLIS STEVEN H Executive Chairman | Option exercise 10b5-1 | +12,578 | $86.09 | $1.1M | 332,490.67 |
| 2025-03-25 | COLLIS STEVEN H Executive Chairman | Sale 10b5-1 | −12,578 | $269.51 | $3.4M | 319,912.67 |
| 2025-03-25 | COLLIS STEVEN H Executive Chairman | Sale 10b5-1 | −2,000 | $269.51 | $539K | 317,912.67 |
| 2025-03-25 | COLLIS STEVEN H Executive Chairman | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −12,578 | 150,942 | ||
| 2025-03-24 | Campbell Elizabeth S Executive Vice President | Sale 10b5-1 | −2,127 | $268.28 | $571K | 16,664.53 |
| 2025-03-24 | Campbell Elizabeth S Executive Vice President | Sale 10b5-1 | −2,000 | $268.28 | $537K | 14,664.53 |
| 2025-03-18 | Mauch Robert P. President & CEO | Option exercise 10b5-1 | +3,226 | $86.09 | $278K | 54,296 |
Page 11 of 40 · 797 trades